184 related articles for article (PubMed ID: 35032639)
1. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio reflect disease activity and flares in patients with systemic lupus erythematosus - A prospective study.
Cho J; Liang S; Lim SHH; Lateef A; Tay SH; Mak A
Joint Bone Spine; 2022 Jul; 89(4):105342. PubMed ID: 35032639
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: A meta-analysis.
Ma L; Zeng A; Chen B; Chen Y; Zhou R
Int Immunopharmacol; 2019 Nov; 76():105949. PubMed ID: 31634817
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus.
Wu Y; Chen Y; Yang X; Chen L; Yang Y
Int Immunopharmacol; 2016 Jul; 36():94-99. PubMed ID: 27111516
[TBL] [Abstract][Full Text] [Related]
4. Predicting flares in patients with stable systemic lupus erythematosus.
Cho J; Lahiri M; Teoh LK; Dhanasekaran P; Cheung PP; Lateef A
Semin Arthritis Rheum; 2019 Aug; 49(1):91-97. PubMed ID: 30660381
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis.
Soliman WM; Sherif NM; Ghanima IM; El-Badawy MA
Reumatol Clin (Engl Ed); 2020; 16(4):255-261. PubMed ID: 30166230
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients.
Qin B; Ma N; Tang Q; Wei T; Yang M; Fu H; Hu Z; Liang Y; Yang Z; Zhong R
Mod Rheumatol; 2016; 26(3):372-6. PubMed ID: 26403379
[TBL] [Abstract][Full Text] [Related]
7. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Cho J; Shen L; Huq M; Kandane-Rathnayake R; Golder V; Louthrenoo W; Chen YH; Hamijoyo L; Luo SF; Wu YJ; Zamora L; Li Z; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake D; Chan M; Kikuchi J; Takeuchi T; Bae SC; Oon S; O'Neill S; Goldblatt F; Ng KPL; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Navarra SV; Lau CS; Hoi A; Morand EF; Nikpour M; Lateef A;
Lancet Rheumatol; 2023 Oct; 5(10):e584-e593. PubMed ID: 38251484
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus.
Kim HA; Jung JY; Suh CH
Clin Rheumatol; 2017 Nov; 36(11):2479-2485. PubMed ID: 28840341
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Hematological Indices in Patients of Systemic Lupus Erythematous and Its Correlation with SLEDAI-2K.
Meena VP; Meena PD; Chejara RS; Nawal CL; Singh A; Rankawat G
J Assoc Physicians India; 2023 Nov; 71(11):40-42. PubMed ID: 38720495
[No Abstract] [Full Text] [Related]
10. Predictors of flare in SLE patients fulfilling lupus low disease activity state: a cohort study of 292 patients with 36-month follow-up.
Cunha RN; Saraiva L; Jesus D; Doria A; da Silva JP; Inês LS
Rheumatology (Oxford); 2023 Nov; 62(11):3627-3635. PubMed ID: 36847423
[TBL] [Abstract][Full Text] [Related]
11. The role of MBL, PCT, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus.
Musunuri B; Tripathy R; Padhi S; Panda AK; Das BK
Clin Rheumatol; 2022 Nov; 41(11):3337-3344. PubMed ID: 35835900
[TBL] [Abstract][Full Text] [Related]
12. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
[TBL] [Abstract][Full Text] [Related]
13. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
14. Differential parameters between activity flare and acute infection in pediatric patients with systemic lupus erythematosus.
Luo KL; Yang YH; Lin YT; Hu YC; Yu HH; Wang LC; Chiang BL; Lee JH
Sci Rep; 2020 Nov; 10(1):19913. PubMed ID: 33199770
[TBL] [Abstract][Full Text] [Related]
15. Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature.
Arnaud L; Furie R; Morand EF; Aringer M; Peschken C; Desta B; Rapsomaniki E; Hedberg J; Knagenhjelm J; Seo C; Grünfeld Eén T; Sorrentino A; Tummala R; Stirnadel-Farrant HA; Ding B
Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38123459
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratios and platelet-to-lymphocyte ratios in juvenile systemic lupus erythematosus: correlation with disease manifestations.
Li W; Liu S; Chen C; Han Y
Ann Palliat Med; 2021 Sep; 10(9):9406-9414. PubMed ID: 34628866
[TBL] [Abstract][Full Text] [Related]
17. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.
Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
Lupus; 2021 Sep; 30(10):1586-1595. PubMed ID: 34192957
[TBL] [Abstract][Full Text] [Related]
18. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
Zen M; Bassi N; Nalotto L; Canova M; Bettio S; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
Clin Exp Rheumatol; 2012; 30(6):856-63. PubMed ID: 22765883
[TBL] [Abstract][Full Text] [Related]
19. Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
Suszek D; Górak A; Majdan M
Rheumatol Int; 2020 Oct; 40(10):1625-1629. PubMed ID: 32772131
[TBL] [Abstract][Full Text] [Related]
20. How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
Thanou A; Chakravarty E; James JA; Merrill JT
Rheumatology (Oxford); 2014 Dec; 53(12):2175-81. PubMed ID: 24729400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
